Synaptogenix Historical Financial Ratios

SNPX Stock  USD 2.72  0.01  0.37%   
Synaptogenix is promptly reporting on over 81 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Book Value Per Share of 33.95, Invested Capital of 0.0, Average Payables of 1 M or Stock Based Compensation To Revenue of 0.0 will help investors to properly organize and evaluate Synaptogenix financial condition quickly.
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Synaptogenix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
For more information on how to buy Synaptogenix Stock please use our How to Invest in Synaptogenix guide.

About Synaptogenix Financial Ratios Analysis

SynaptogenixFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Synaptogenix investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Synaptogenix financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Synaptogenix history.

Synaptogenix Financial Ratios Chart

At this time, Synaptogenix's Payables Turnover is fairly stable compared to the past year. EV To Operating Cash Flow is likely to rise to 5.17 in 2024, whereas PTB Ratio is likely to drop 0.12 in 2024.
Add Fundamental
Price To Sales RatioDividend Yield
Ptb RatioDays Sales Outstanding
Book Value Per ShareFree Cash Flow Yield
Invested CapitalOperating Cash Flow Per Share
Average PayablesStock Based Compensation To Revenue
Capex To DepreciationPb Ratio
Ev To SalesFree Cash Flow Per Share
RoicInventory Turnover
Net Income Per ShareDays Of Inventory On Hand
Payables TurnoverSales General And Administrative To Revenue
Average InventoryResearch And Ddevelopement To Revenue
Capex To RevenueCash Per Share
PocfratioInterest Coverage
Payout RatioCapex To Operating Cash Flow
Pfcf RatioDays Payables Outstanding
Net Current Asset ValueIncome Quality
RoeTangible Asset Value
Ev To Operating Cash FlowPe Ratio
Return On Tangible AssetsEv To Free Cash Flow
Earnings YieldIntangibles To Total Assets
Net Debt To E B I T D ACurrent Ratio
Tangible Book Value Per ShareReceivables Turnover
Graham NumberShareholders Equity Per Share
Debt To EquityCapex Per Share
Graham Net NetAverage Receivables
Revenue Per ShareInterest Debt Per Share
Debt To AssetsEnterprise Value Over E B I T D A
Short Term Coverage RatiosPrice Earnings Ratio
Price Book Value RatioPrice Earnings To Growth Ratio
Days Of Payables OutstandingDividend Payout Ratio
Price To Operating Cash Flows RatioPrice To Free Cash Flows Ratio
Pretax Profit MarginEbt Per Ebit
Operating Profit MarginEffective Tax Rate
Company Equity MultiplierLong Term Debt To Capitalization
Total Debt To CapitalizationReturn On Capital Employed
Debt Equity RatioEbit Per Revenue
Quick RatioDividend Paid And Capex Coverage Ratio
Net Income Per E B TCash Ratio
Operating Cash Flow Sales RatioDays Of Inventory Outstanding
Days Of Sales OutstandingFree Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage RatiosPrice To Book Ratio
Fixed Asset TurnoverCapital Expenditure Coverage Ratio
Price Cash Flow RatioEnterprise Value Multiple
Debt RatioCash Flow To Debt Ratio
Price Sales RatioReturn On Assets
Asset TurnoverNet Profit Margin
Gross Profit MarginPrice Fair Value
Return On Equity

Dividend Yield

Dividend Yield is Synaptogenix dividend as a percentage of Synaptogenix stock price. Synaptogenix dividend yield is a measure of Synaptogenix stock productivity, which can be interpreted as interest rate earned on an Synaptogenix investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.

Ptb Ratio

Price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value.

Book Value Per Share

The ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements.

Average Payables

The average amount owed to suppliers and creditors over a specific period, reflecting the company's payment cycle and credit terms with suppliers.

Inventory Turnover

A ratio showing how many times a company's inventory is sold and replaced over a period, indicating the efficiency of inventory management.
Most ratios from Synaptogenix's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Synaptogenix current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Synaptogenix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
For more information on how to buy Synaptogenix Stock please use our How to Invest in Synaptogenix guide.At this time, Synaptogenix's Payables Turnover is fairly stable compared to the past year. EV To Operating Cash Flow is likely to rise to 5.17 in 2024, whereas PTB Ratio is likely to drop 0.12 in 2024.
 2021 2023 2024 (projected)
PTB Ratio31.820.130.12
Dividend Yield5.72E-40.20.21

Synaptogenix fundamentals Correlations

-0.380.22-0.84-0.2-0.08-0.55-0.38-0.20.12-0.170.420.240.59-0.06-0.050.59-0.06-0.440.00.60.70.020.6-0.860.35
-0.38-0.760.480.710.170.061.00.71-0.710.670.16-0.77-0.750.11-0.27-0.75-0.55-0.06-0.69-0.77-0.7-0.72-0.770.54-0.74
0.22-0.76-0.07-0.990.440.21-0.76-0.990.54-0.98-0.681.00.61-0.630.630.610.94-0.420.380.610.690.380.61-0.160.4
-0.840.48-0.070.010.460.810.480.01-0.37-0.04-0.62-0.09-0.41-0.430.14-0.410.260.12-0.32-0.43-0.45-0.37-0.431.0-0.7
-0.20.71-0.990.01-0.51-0.270.711.0-0.451.00.73-0.99-0.610.69-0.6-0.61-0.960.45-0.29-0.62-0.7-0.29-0.620.1-0.32
-0.080.170.440.46-0.510.30.17-0.51-0.06-0.55-0.70.42-0.11-0.760.64-0.110.63-0.78-0.27-0.120.09-0.31-0.120.41-0.31
-0.550.060.210.81-0.270.30.06-0.27-0.32-0.31-0.590.190.18-0.650.010.180.440.25-0.220.150.07-0.260.150.78-0.62
-0.381.0-0.760.480.710.170.060.71-0.710.670.16-0.77-0.750.11-0.27-0.75-0.55-0.06-0.69-0.77-0.7-0.72-0.770.54-0.74
-0.20.71-0.990.011.0-0.51-0.270.71-0.451.00.73-0.99-0.610.69-0.6-0.61-0.960.45-0.29-0.62-0.7-0.29-0.620.1-0.32
0.12-0.710.54-0.37-0.45-0.06-0.32-0.71-0.45-0.41-0.060.540.120.160.670.120.36-0.050.960.150.120.950.15-0.40.86
-0.170.67-0.98-0.041.0-0.55-0.310.671.0-0.410.76-0.98-0.590.73-0.6-0.59-0.970.46-0.24-0.59-0.68-0.24-0.590.05-0.27
0.420.16-0.68-0.620.73-0.7-0.590.160.73-0.060.76-0.67-0.090.72-0.54-0.09-0.890.350.06-0.08-0.170.08-0.08-0.550.17
0.24-0.771.0-0.09-0.990.420.19-0.77-0.990.54-0.98-0.670.62-0.620.630.620.93-0.420.390.620.70.390.62-0.180.41
0.59-0.750.61-0.41-0.61-0.110.18-0.75-0.610.12-0.59-0.090.62-0.41-0.131.00.43-0.010.111.00.960.131.0-0.450.22
-0.060.11-0.63-0.430.69-0.76-0.650.110.690.160.730.72-0.62-0.41-0.42-0.41-0.750.530.3-0.39-0.510.34-0.39-0.360.43
-0.05-0.270.630.14-0.60.640.01-0.27-0.60.67-0.6-0.540.63-0.13-0.42-0.130.65-0.590.49-0.120.020.44-0.120.080.32
0.59-0.750.61-0.41-0.61-0.110.18-0.75-0.610.12-0.59-0.090.621.0-0.41-0.130.43-0.010.111.00.960.131.0-0.450.22
-0.06-0.550.940.26-0.960.630.44-0.55-0.960.36-0.97-0.890.930.43-0.750.650.43-0.420.210.430.510.20.430.180.15
-0.44-0.06-0.420.120.45-0.780.25-0.060.45-0.050.460.35-0.42-0.010.53-0.59-0.01-0.420.24-0.01-0.280.25-0.010.170.0
0.0-0.690.38-0.32-0.29-0.27-0.22-0.69-0.290.96-0.240.060.390.110.30.490.110.210.240.140.031.00.14-0.340.82
0.6-0.770.61-0.43-0.62-0.120.15-0.77-0.620.15-0.59-0.080.621.0-0.39-0.121.00.43-0.010.140.960.161.0-0.480.26
0.7-0.70.69-0.45-0.70.090.07-0.7-0.70.12-0.68-0.170.70.96-0.510.020.960.51-0.280.030.960.050.96-0.510.23
0.02-0.720.38-0.37-0.29-0.31-0.26-0.72-0.290.95-0.240.080.390.130.340.440.130.20.251.00.160.050.16-0.380.86
0.6-0.770.61-0.43-0.62-0.120.15-0.77-0.620.15-0.59-0.080.621.0-0.39-0.121.00.43-0.010.141.00.960.16-0.480.26
-0.860.54-0.161.00.10.410.780.540.1-0.40.05-0.55-0.18-0.45-0.360.08-0.450.180.17-0.34-0.48-0.51-0.38-0.48-0.72
0.35-0.740.4-0.7-0.32-0.31-0.62-0.74-0.320.86-0.270.170.410.220.430.320.220.150.00.820.260.230.860.26-0.72
Click cells to compare fundamentals

Synaptogenix Account Relationship Matchups

Synaptogenix fundamentals Accounts

201920202021202220232024 (projected)
Ptb Ratio29.3636.7131.825.720.130.12
Book Value Per Share2.934.096.695.0754.8933.95
Free Cash Flow Yield(0.0232)(0.043)(0.008167)(0.0553)(1.63)(1.55)
Operating Cash Flow Per Share(2.0)(6.44)(1.74)(1.6)(11.1)(11.65)
Capex To Depreciation1.191.110.641.30.430.41
Pb Ratio29.3636.7131.825.720.130.12
Free Cash Flow Per Share(2.0)(6.45)(1.74)(1.61)(11.11)(11.66)
Roic(0.87)(2.06)(0.38)(0.73)(0.34)(0.36)
Net Income Per Share(2.48)(11.33)(2.51)(0.78)(12.96)(13.6)
Payables Turnover0.01060.0038660.003830.0086550.01430.015
Cash Per Share2.924.616.825.3664.5837.69
Pocfratio(43.03)(23.28)(122.49)(18.08)(0.61)(0.64)
Capex To Operating Cash Flow(4.39E-4)(6.68E-4)(3.67E-4)(6.61E-4)(5.23E-4)(5.49E-4)
Pfcf Ratio(43.01)(23.27)(122.44)(18.07)(0.61)(0.64)
Days Payables Outstanding34.4K94.4K95.3K42.2K25.6K24.3K
Income Quality0.790.640.692.010.860.76
Roe(0.85)(2.77)(0.38)(0.15)(0.25)(0.26)
Ev To Operating Cash Flow(41.57)(22.57)(118.56)(14.74)4.935.17
Pe Ratio(34.66)(13.24)(84.65)(37.14)(0.52)(0.55)
Return On Tangible Assets(0.82)(2.11)(0.35)(0.14)(0.19)(0.2)
Ev To Free Cash Flow(41.55)(22.55)(118.52)(14.73)4.935.17
Earnings Yield(0.0288)(0.0755)(0.0118)(0.0269)(1.91)(1.81)
Net Debt To E B I T D A1.120.522.712.323.453.62
Current Ratio37.324.1717.829.397.146.78
Tangible Book Value Per Share2.934.096.695.0754.8933.95
Graham Number12.7932.2819.449.44123.498.68
Shareholders Equity Per Share2.934.096.695.0752.2433.45
Capex Per Share8.77E-40.0043046.38E-40.0010610.0058080.004782
Graham Net Net2.843.46.424.9152.7232.85
Enterprise Value Over E B I T D A(31.86)(16.4)(81.88)(10.24)3.073.22
Price Earnings Ratio(34.66)(13.24)(84.65)(37.14)(0.52)(0.55)
Price Book Value Ratio29.3636.7131.825.720.130.12
Days Of Payables Outstanding34.4K94.4K95.3K42.2K25.6K24.3K
Price To Operating Cash Flows Ratio(43.03)(23.28)(122.49)(18.08)(0.61)(0.64)
Price To Free Cash Flows Ratio(43.01)(23.27)(122.44)(18.07)(0.61)(0.64)
Ebt Per Ebit0.981.341.00.210.730.96
Effective Tax Rate0.025(0.12)5.64E-40.02080.01870.0196
Company Equity Multiplier1.031.311.061.091.280.92
Return On Capital Employed(0.89)(1.84)(0.38)(0.71)(0.31)(0.33)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Synaptogenix Stock Analysis

When running Synaptogenix's price analysis, check to measure Synaptogenix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Synaptogenix is operating at the current time. Most of Synaptogenix's value examination focuses on studying past and present price action to predict the probability of Synaptogenix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Synaptogenix's price. Additionally, you may evaluate how the addition of Synaptogenix to your portfolios can decrease your overall portfolio volatility.